Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

Prior treatment

• Patient with Neuromuscular inadequacy (e.g. Prior paralysis, fusion and or inadequate abductor strength)
• Previous ankle arthrodesis with excision of the malleoli

Other illness

• Patient with Infection at the ankle site or infection at distant sites that could migrate to the ankle
• Patient with Neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing
• Patient with dementia
• Patient with known metal allergies

Age

• Skeletally immature patients (patient is less than 21 years if age at time of surgery)

Other

• Patient with excessive bone loss at the ankle joint site
• Patient with severe osteoporosis
• Patient with complete talar avascular necrosis
• Patient with Active Osteomyelitis
• Patient with Sepsis
• Patient with Vascular deficiency in the involved limb
• Patient with Neuropathic joints
• Patient with Poor soft tissue coverage around the ankle
• Patient with Charcot arthropathy
• Excessive loads as caused by activity or patient weight - per investigator discretion
• Patient who is pregnant

• Patient is indicated for total ankle arthroplasty
• Patient is skeletally mature
• Patient is mentally capable of completing follow-up forms
• Patient will be available for follow-up out to 10 years
• Patient has been deemed a candidate for Ankle replacement by diagnosis of the investigator
• Patient is willing and able to read and sign a study informed consent form